Academic Health Center
Stay Connected
research-and-clinical-trials

Fulbright-Saastamoinen Foundation Grant helps speed up research on Parkinson’s disease, multiple sclerosis and deep brain stimulation

A six-month Fulbright-Saastamoinen Foundation Grant provided a collaboration boost between Shalom Michaeli, Ph.D., professor at the Center for Magnetic Resonance Research (CMRR) at the University of Minnesota and Olli Gröhn, Ph.D., professor and director of the magnetic resonance imaging (MRI) unit and vice director of the A.I. Virtanen Institute for Molecular Science at Kuopio Campus at the University of Eastern Finland.

“During my time in Finland, we made significant progress in establishing MRI biomarkers for Parkinson’s disease (PD) and multiple sclerosis (MS),” said Michaeli. “Noninvasive MRI rotating frame relaxation contrasts developed at the CMRR in close collaboration with the Kuopio team are highly sensitive to slow motion, and could probe critically important processes, such as demyelination, and could serve as noninvasive biomarkers for PD and MS.”

Read more
research-and-clinical-trials

Research Snapshot: U of M study finds possible delay of disability progression in multiple sclerosis

Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system which can lead to blurred vision, balance issues, tremors and even paralysis amongst other issues.

An estimated 2.1 million people have MS but it is believed to be much higher because the CDC does not require U.S. physicians to report new cases.

In a study recently published in the Journal of Neuroscience, University of Minnesota neuroscientist Wensheng Lin, M.D., Ph.D., took a closer look at the relationship of myelin and oligodendrocytes (cells responsible for the formation of myelin in the central nervous system) in mice with MS.

Read more